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Abstract
Transgenesis may allow the generation of farm animals with altered phenotype, animal models for research and
animal bioreactors. Although such animals have been produced, the time and expense involved in generating
transgenic livestock and then evaluating the transgene expression pattern is very restrictive. If questions about the
ability and efficiency of expression could be asked solely in vitro rapid progress could be achieved. Unfortunately,
experiments addressing transcriptional control in vitro have proved unreliable in their ability to indicate whether
a transgene will be transcribed or not. However, initial studies suggest that cell culture may be able to predict in
vivo post-transcriptional events. We review these issues and propose that strategies which engineer the transgene
integration site could enhance the probability for efficient expression. This approach has now become feasible
with the development of techniques allowing animals to be generated from somatic cells by nuclear transfer. The
important step in this procedure is the use of cells grown in culture as the source of genetic information, allowing the
selection of specific transgene integration events. This technology which has dramatically increased the potential
use of transgenic livestock for both agricultural and biotechnological applications, is based on standard cell culture
methodology. We are now at the start of a new era in large animal transgenics.
Introduction
A transgenic animal is one which carries integrated
sequences of cloned DNA in its genome. The intro-
duced DNA can be derived from species other than
the host and can be modified in vitro prior to being
introduced into the germline. Therefore, transgenic
livestock overcome the limitations of classical an-
imal breeding regimes, where importation of genes
by cross-breeding is limited to those traits already
present within a given species. Transgenesis may al-
low the generation of farm animals with altered phen-
otype (e.g. enhanced growth rate), animal models
for research (e.g. to evaluate somatic gene therapy
strategies) and animal bioreactors. It is this last oppor-
tunity which has seen the most progress over the last
decade, with the expression of a variety of proteins
having been targeted to the milk of sheep, cattle, pigs,
goats and rabbits (Wilmut et al., 1997).
The time and expense involved in generating trans-
genic livestock and then evaluating the transgene ex-
pression pattern is very restrictive. If questions about
the ability and efficiency of expression could be asked
solely in vitro rapid progress could be achieved. In
this article, we will describe the various stages at
which transgenes can be assessed in cell culture in
vitro prior to their incorporation into livestock; and
discuss the validity and usefulness of these studies for
transgenic livestock produced by microinjection and
nuclear transfer.
Expression assay systems: cells versus animals
Transcription of eukaryotic genes requires that the
gene sequence is present within chromatin and that
it has been exposed to the relevant developmental
cues. Therefore, different experimental assay sys-
tems each have an inherent stringency with regard to
identifying transcription control elements. The least
stringent assay, transient transfection of cells grown
in culture where the introduced plasmid DNA remains
4episomal, does not result in the appropriate chromatin
structure being formed. The appropriate chromatin
structure can be established in stably-transfected cells,
where (usually) the introduced plasmid DNA has in-
tegrated into the host cell’s genome, but the gene
does not experience the full repertoire of develop-
mental signals. In transgenic animals, however, both
criteria are achieved. The introduced DNA fragment
integrates into the host genome and can be inherited
in a Mendelian manner. However, gene constructs
transferred into the germline using the microinjection
method suffer from position-effects (Al-Shawi et al.,
1990; Clark et al., 1994).
Position-effects are due to the conformational de-
mands imposed by the chromatin structure at the site
of transgene integration, the complexity of the trans-
gene array and the actual sequences present within
the transgene. The influence this has on expression
can vary considerably; generating no or variegated ex-
pression, or resulting in ectopic transgene expression
(Farini and Whitelaw, 1995). The expression poten-
tial for a given transgene at a given integration site
must reside in the chromatin structure the transgene
either imposes on itself, regardless of the neighbouring
chromatin, or the chromatin structure it finds itself in.
As a corollary of this, it is reasonable to propose that
strategies which engineer the transgene integration site
could enhance the probability for efficient expression.
Determining transcription potential
In transgenic animals, tissue-specific and physiologic-
ally regulated expression of the transgene will arise
only by including the appropriate genetic elements
within its structure. Transcription initiation is a mul-
tistep process which involves interactions between the
gene proximal basal transcription machinery and more
distal elements (Kronberg, 1996). These distal ele-
ments are diverse in nature, responding to spatial
and temporal stimuli, and include chromatin opening
and polymerase modulating activities. Together the
transcription complex determines the likelihood of a
given gene being expressed. Identification of DNA
elements capable of regulating gene expression has
relied heavily on transfer of gene fragments into cells
grown in culture. However, gene regulatory elements
have been identified in vivo which were not apparent
in cell culture studies (Brinster et al., 1988; com-
pare Burdon et al., 1994 and Webster et al., 1995).
Furthermore, a comparison of the effect of various reg-
ulatory elements showed examples of high efficiency
of expression in vitro and only moderately efficient
expression in vivo (Petitclerc et al., 1995).
These differences can relate to specific transcrip-
tional control elements or present as more generic
differences. For example, molecular analysis of the
distal enhancer of the mouse -fetoprotein gene has
shown that mutations to specific transcription factor
binding sites in the enhancer caused a 10-fold reduc-
tion in enhancer function in vitro, whereas in trans-
genic mice, the same mutation resulted in sporadic
tissue-specific expression of the transgene, depend-
ent on the site of integration (Millonig et al., 1995).
In contrast, mutations to the glucocorticoid receptor
element within the ovine -lactoglobulin (BLG) pro-
moter all but abolished expression in transfected cells
but had no effect on expression in transgenic mice, as
compared to wild-type constructs (Tom Burdon, per-
sonal communication). The same contrariety between
in vitro and in vivo experiments is also observed
for the basal transcriptional machinery. Mutagenesis
of the B-crystallin TATA box sequence had no ef-
fect on promoter activity in transfected lens cells but
preferentially reduced promoter activity in the lens
of transgenic mice (Haynes et al., 1997). Therefore,
when comparing cell transfection and transgenic mice,
it would seem that regulation of transcription dif-
fers in vitro from in vivo at the levels of both the
basal transcription machinery and upstream regulatory
elements.
There is now considerable evidence to support the
hypothesis that a more stringent requirement for in-
trons exists in transgenic mice than in cell culture. For
example, whilst introns increase transcriptional effi-
ciency of metallothionein-I promoter driven rat growth
hormone gene constructs in transgenic mice, expres-
sion in cultured cells seems to be insensitive to the
presence of introns (Brinster et al., 1988). Through
our study of the ovine BLG gene we have also en-
countered this phenomenon. Genomic gene fragments
of BLG are expressed in a position-dependent manner
in the mammary gland of transgenic mice (Whitelaw
et al., 1992), while an intronless BLG transgene which
retained both 30- and 50-flanking sequences was found
to be position-dependent. A transgene is said to be ex-
pressed in a position-dependent manner when expres-
sion is seen in only a proportion of the lines generated:
expression is silenced in some lines. We have demon-
strated that BLG intron removal per se increases the
sensitivity of BLG transgenes to position effects in
vivo, whilst having no effect on expression in vitro
5(Webster et al., 1997). This suggests that introns play a
role in facilitating transcription of microinjected genes
and that this effect manifests only on genes exposed
to developmental influences, after passing through the
germline. There is also the possibility that the differ-
ences between in vivo and in vitro results could reflect
the inherent differences between a microinjected lin-
ear transgene and supercoiled transfected plasmids or
be a property of cell lines per se.
It is now becoming apparent that position effects
can also result in variable levels of transgene ex-
pression, either between individual transgenic animals
within a given line or between individual transgenic
lines. For example, analysis of transgenic mouse lines
carrying the -globin promoter linked to the lacZ re-
porter indicated that cells either do not express the
transgene or express it at a level characteristic of that
line (Robertson et al., 1995). In other words, the num-
ber of expressing cells varies greatly between different
lines, but there is a similar percentage of expressing
cells within the line. Discrete patches of transgene ex-
pressing cells surrounded by non-expressing cells have
also been observed in the mammary gland of trans-
genic mouse lines expressing BLG transgenes (Dobie
et al., 1996). It has been proposed that variegated
silencing may be a consequence of the proximity of
the transgene array to centromeric heterochromatin
(Dobie et al., 1996) or that multicopy transgene arrays
may themselves act as the focus for heterochromatin
formation (Dorer et al., 1997).
These expression patterns can be explained by a
binary model of expression. This model suggests that a
percentage of cells are able to form an active transcrip-
tion complex and the level of expression is the same in
each expressing cell. In the binary model, enhancers
increase the number of cells able to undergo transcrip-
tion by preventing gene repression in individual cells
(Walters et al., 1995). In contrast, transgenic mice
carrying the -globin promoter linked to the lacZ re-
porter showed graded expression on a cell-to-cell basis
both within and between transgenic lines (Hammer
et al., 1985). The binary effect can be evaluated in
cell culture (Walters et al., 1995), however it remains
to be determined whether graded expression can be
modelled in vitro.
Assessment of post-transcriptional events in vitro
Modulation of any of the events between transcrip-
tion and post-translation modification of the protein
could have significant effects on final product levels.
This area of gene regulation has not been adequately
addressed in transgenic animals: most of the accu-
mulated knowledge on transgene expression concerns
transcription potential.
Modulation of the half life and translational po-
tential of mRNA can give rise to large variations in
the levels of protein synthesis, independently of any
change in transcriptional activity. It is also likely that
improper splicing, polyadenylation and nuclear trans-
port or the generation of an unstable cytosolic mRNA
will result in the accumulation of low-levels of mRNA,
hence reduced protein production. For example, aber-
rant splicing has been associated with poor expression
of human factor IX transgenes in mice. Analysis of
the transgene transcript uncovered a cryptic splice site,
removal of which resulted in an increase in factor
IX production (Yull et al., 1995). A similar situation
has been reported for CD46 transgenes (Mulder et al.,
1997).
Transcriptional control mechanisms observed in
vivo are often not consistent with those acting in
vitro. However, pre-mRNA processing mechanisms
observed in cell culture have been shown to correlate
with the post-transcriptional modifications observed in
transgenic mice. For example, BLG minigene con-
structs were inefficiently spliced, with the frequency
of intron retention similar in vitro and in vivo (Dono-
frio et al., 1996). The availability of an in vitro system
that mirrors RNA processing events in vivo is likely
to allow testing of transgene constructs for efficient
post-transcriptional modifications prior to their use in
livestock. As more effort is targeted to addressing
post-transcriptional processing events in transgenic
animals the validity of cell culture models is gaining
strength (Seipelt et al., 1998).
The requirement for introns to achieve optimal
mRNA processing is a problem in achieving efficient
transgene expression, particularly for large genes. In
this context, viral mRNAs, although not containing
introns, are efficiently processed. For example, reg-
ulatory sequences such as the constitutive transport
element of simian retrovirus type-1 augment the trans-
lational potential of mRNA transcripts, by command-
eering endogenous cellular factors (Saavedra et al.,
1997). It is possible that RNA elements could facilitate
the translational potential of cDNA based transgenes.
These types of constructs can be evaluated in vitro.
It may also be possible to modulate post-
translational maturation of the transgene product. For
example, inefficient endo-proteolytic processing of a
6transgene encoded human protein C has been rescued
through the co-expression of the processing enzyme
furin (Drews et al., 1995). Again, it may be possible to
assess protein processing issues in an in vitro system.
Nuclear transfer: a new era for cell culture
Transgenic livestock, until recently (Schnieke et al.,
1997), were generated by the direct DNA microin-
jection of fertilised eggs, with the first transgenic
livestock produced over a decade ago (Hammer et al.,
1985). The microinjection route is inefficient, primar-
ily due to the large number of animals required: 1%
of the eggs injected result in a transgenic animal.
This approach is also limited by the random nature of
transgene integration, with both the site of integration
and the number of integrated copies influencing trans-
gene expression (Al-Shawi et al., 1990; Clark et al.,
1994; Garrick et al., 1997). In addition, microinjection
can only add genes. Taken together, these limitations
have been the driving force for the development of a
cell-based approach to generating transgenic livestock.
For many years targeted integration has been pos-
sible in the mouse model through embryonic stem
(ES) cell technology (Thompson et al., 1989). ES
cells are unique, in that they allow efficient homolog-
ous recombination events to occur between introduced
DNA fragments (the transgene) and endogenous ge-
nomic loci, while remaining pluripotent. Although
there has been considerable effort to generate ruminant
ES cells, to date all attempts have been unsuccessful.
The application of the recently developed selection
protocol for embryonic cells that kills differentiated
cells while leaving the undifferentiated (and pluri-
potent) cells to grow (McWhir et al., 1996), may
now provide a route to generate ruminant ES cells.
An alternative approach, and one which has gener-
ated considerable attention through the generation of
Dolly (www.ri.bbsrc.ac.uk), involves the transfer of
nuclear genetic material from cells grown in culture
into an unfertilised egg cell (Campbell et al., 1996;
Wilmut et al., 1997). Now rather than merely evalu-
ating a transgene construct in cell culture, the actual
cell is the genetic material from which the transgenic
animal is generated. Transgenic livestock have been
produced using this technology, e.g. sheep carrying a
human factor IX transgene (Schnieke et al., 1997). The
gateway has been opened for the production of a vari-
ety of livestock for both agricultural and biomedical
applications.
There are many advantages to this technology; all
founder animals are transgenic, mosaic founders are
not produced, the sex of the founder can be selected
and a flock/herd of clonal animals can be produced
within one generation. More importantly, many as-
pects of the transgene can be analysed in vitro prior
to the generation of an animal. The integrity of the
transgene locus can be evaluated which may be par-
ticularly important when large transgenes, e.g. yACs,
are used. Furthermore, with some ingenuity, it will
be possible to check the expression potential of a
transgene before going through the cost of producing
the animal. Expression strategies could, for example,
involve the transient expression of the appropriate
receptor (Lesueur et al., 1990) or DNA which can me-
diate trans-induction of expression (Ashe et al., 1997).
The most important point, however, is that site-specific
integration events through homologous recombination
can be selected for, thus allowing strategies involving
gene knock-out or replacement to be performed. The
mouse model has already shown the feasibility of such
strategies for the milk protein -lactalbumin (Stacey
et al., 1995). Future transgenic livestock will prob-
ably have the transgene integrated into a permissive
site. Although the appropriate genomic site remains
to be determined, the approach has been evaluated in
the mouse model (Bronson et al., 1996; Melton et al.,
1997).
A cell-based method to produce transgenic live-
stock allows single-copy transgene integrants at pre-
determined sites to be generated, which should limit
problems such as variegated transgene expression
(Garrick et al., 1997). The outcome is certainly likely
to be more predictable and generate the anticipated
transgene expression profile, but will expression levels
be high enough? Multiple-copy transgene loci given
the right position-effect can give very high-levels of
expression. The next generation of transgenes may
well have promoters optimised for transcription factor
complex formation thereby increasing the probability
of transcription and incorporate elements capable of
enhancing mRNA processing. It is likely that many
of these issues can be evaluated in cells prior to
generating a transgenic animal.
Conclusion
The study of gene expression in vitro has greatly in-
creased our understanding of transcription and mRNA
processing mechanisms and will continue to do so.
7It has, however, been limited in its capacity to act
as a predictor of how a transgene will function in
the whole animal. The recent development of tech-
niques allowing animals to be generated from somatic
cells by nuclear transfer is the start of an new era in
large animal transgenics. The important step in this
procedure is the use of cells grown in culture as the
source of genetic information, allowing the selection
of specific transgene integration events. This techno-
logy which has dramatically increased the potential
use of transgenic livestock for both agricultural and bi-
otechnological applications, is based on standard cell
culture methodology.
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